Previous research showed that silencing of YAP expression enhanced the in vitro sensitivity to MEK and RAF inhibitors in lung cancer, colon cancer, melanoma, pancreatic cancer and thyroid cancer.26 Here, MAP2K7 is linked to lung carcinoma.